Co Dopa CR 250 mg is a controlled-release antiparkinsonian medication combining Levodopa 200 mg and Carbidopa 50 mg. It is used in the treatment of Parkinson’s disease and Parkinsonism-related movement disorders. The controlled-release formulation allows for a slower, steady release of the drug, helping to maintain stable blood levels and reduce the frequency of "off" episodes.